Life Sciences Ontario Announces New Chair, Board Members

March 24, 2017

March 24, 2017

Life Sciences Ontario (LSO) has announced a new Chair of its Board of Directors, along with two new Board members.

Effective immediately, Mark Smithyes will assume the role of Chair; he replaces outgoing Chair Paul Lucas, who is now entering retirement. Smithyes has served on LSO’s Board since 2011 and has a career in the pharma and medical device industries spanning 20 years.

LSO also announced the addition of two new Members to its Board: Susan Marlin, President of Clinical Trials Ontario, and Deborah Brown, a management consultant in the pharmaceutical and biotech industry.